Back
Syros Pharmaceuticals Stock Price Chart
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.
Buy
84
SYRS
Syros Pharmaceuticals
Last Price:
5.24
Seasonality Move:
6.39%
7 Day Trial
ALL ACCESS PASS
$
7
I love this overnight trade happening Thursday
Access my free presentation on these overnight trades right here- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRS is experiencing slight selling pressure.
Syros Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.19 | Buy |
| 20-day SMA: | 5.16 | Buy |
| 50-day SMA: | 5.97 | Sell |
| 200-day SMA: | 4.8 | Buy |
| 8-day EMA: | 5.24 | Buy |
| 20-day EMA: | 5.29 | Buy |
| 50-day EMA: | 5.68 | Sell |
| 200-day EMA: | 5.36 | Buy |
Syros Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 50.67 | Buy |
| Chaikin Money Flow: | -26305 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.78 - 5.54) | Buy |
| Bollinger Bands (100): | (5.24 - 7.32) | Sell |
Syros Pharmaceuticals Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Syros Pharmaceuticals Stock
Is Syros Pharmaceuticals Stock a Buy?
- Syros Pharmaceuticals share price is 5.44 while SYRS 8-day simple moving average is 5.19, which is a Buy signal.
- The stock price of SYRS is 5.44 while Syros Pharmaceuticals 20-day SMA is 5.16, which makes it a Buy.
- Syros Pharmaceuticals 50-day simple moving average is 5.97 while SYRS share price is 5.44, making it a Sell technically.
- SYRS stock price is 5.44 and Syros Pharmaceuticals 200-day simple moving average is 4.80, creating a Buy signal.
SYRS Technical Analysis vs Fundamental Analysis
Buy
84
Syros Pharmaceuticals (SYRS)
is a Buy
Is Syros Pharmaceuticals a Buy or a Sell?
-
Syros Pharmaceuticals stock is rated a Buy
The current Syros Pharmaceuticals [SYRS] share price is $5.44. The Score for SYRS is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
Syros Pharmaceuticals Stock Info
Market Cap:
143.91M
Price in USD:
5.44
Share Volume:
194.99K
Syros Pharmaceuticals 52-Week Range
52-Week High:
8.17
52-Week Low:
2.09
Buy
84
Syros Pharmaceuticals (SYRS)
is a Buy
Syros Pharmaceuticals Share Price Forecast
-
What is the Syros Pharmaceuticals stock price today?
The Syros Pharmaceuticals stock price is 5.44 USD today. -
Will SYRS stock go up or go down?
Syros Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Syros Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Syros Pharmaceuticals is not overvalued.
Is Syros Pharmaceuticals Stock a Buy?
- Syros Pharmaceuticals share price is 5.44 while SYRS 8-day exponential moving average is 5.24, which is a Buy signal.
- The stock price of SYRS is 5.44 while Syros Pharmaceuticals 20-day EMA is 5.29, which makes it a Buy.
- Syros Pharmaceuticals 50-day exponential moving average is 5.68 while SYRS share price is 5.44, making it a Sell technically.
- SYRS stock price is 5.44 and Syros Pharmaceuticals 200-day simple moving average is 5.36, creating a Buy signal.
Fundamental Analysis of Syros Pharmaceuticals
Is Syros Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.95 per share, and a decrease next year of $0.49 per share.
Technical Analysis of Syros Pharmaceuticals
Should I short Syros Pharmaceuticals stock?
- SYRS Moving Average Covergence Divergence (MACD) indicator is -0.16, suggesting Syros Pharmaceuticals is a Sell
- Syros Pharmaceuticals Relative Strength Index (RSI) is 50.67, which suggest Syros Pharmaceuticals is overbought
- The Bollinger Bands (25) for Syros Pharmaceuticals is (4.78 - 5.54), which suggest Syros Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Syros Pharmaceuticals is (5.24 - 7.32), which suggest Syros Pharmaceuticals is a Sell
* Syros Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.